SHINE Announces Name Change
SHINE Medical Technologies has changed its name to SHINE Technologies, the company announced today. According to a release, the new name highlights the company’s core technological competencies, skilled team and…
Category Archives: Biotech
NorthStar Awarded $37M Through DOE
NorthStar Medical Radioisotopes has been awarded $37 million in cooperative agreement funds with the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA), the company announced today. According to a…
Imbed Biosciences, Spartan Medical Partner
Imbed Biosciences has partnered with Spartan Medical, a company that provides an extensive portfolio of advanced medical devices and technologies from premier partners, the company announced recently. According to a…
Cellectar Awarded $2M SBIR Grant
Cellectar Biosciences has been awarded a $2 million Phase II National Institutes of Health (NIH) SBIR grant from the National Cancer Institute (NCI), the company announced recently. According to a…
Invenra Expands Collaboration With Exelixis
Invenra has expanded its discovery and licensing collaboration with Exelixis to include an additional 20 oncology targets, the company announced today. According to a release, the collaboration builds on the…
NorthStar, GE Healthcare Sign Exclusive Agreement
NorthStar Medical Radioisotopes and GE Healthcare signed an exclusive agreement for the manufacturing and distribution of iodine-123 (I-123) capsules in the United States, NorthStar announced recently. According to a release,…
Cellectar, LegoChemBio Collaborate
Cellectar Biosciences and LegoChemBio, a clinical-stage biotechnology company in South Korea, have entered a development and commercialization collaboration, the company announced today. According to a release, the two companies have…
FluGen Awarded $11.4M Grant
FluGen has been awarded an $11.4 million grant from the United States Department of Defense to conduct a safety and immunogenicity study of the influenza vaccine (M2SR, the company announced…
Nimble Therapeutics, RayzeBio Collaborate
Nimble Therapeutics and RayzeBio, a biotech company focused on improving outcomes for people with cancer, have entered a strategic collaboration, the company announced recently. According to a release, the purpose…
SHINE Closes $150M Series C-5 Financing
SHINE Medical Technologies has completed a $150 million Series C-5 financing round led by Koch Disruptive Technologies (KDT), with participation from Fidelity Management & Research Company, Baillie Gifford and other…
